Nordea Bank Abp: First Quarter Results 2019
COPENHAGEN, Denmark, April 30, 2019 (GLOBE NEWSWIRE) --
First Quarter Results 2019
Nordea Bank Abp - Inside information - Interim report (Q1 and Q3)
CEO Casper von Koskull's comments on the results:
"Through the actions we have taken in recent quarters there are now some encouraging signs of improved business momentum, although lending margins are under continued pressure and market making activities remain challenging.
Compared to the previous quarter, reported revenues were largely unchanged while revenues excluding items affecting comparability increased by 4%. Reported costs increased by 5%, while adjusted for resolution fees in this quarter and excluding items affecting comparability were down 7%.
Our priorities are very clear - to increase business momentum and at the same time reduce the structural cost base; we are executing on both.
This quarter, there has been an intense debate about various anti-money laundering ("AML") issues. It is a very complex and broad issue in society and we take our responsibility very seriously. We have previously stated that we expect to be fined in Denmark for our past weak AML processes and procedures, and we are consequently making a provision of EUR 95m for AML-related matters. Having invested more than EUR 700m in strengthening our risk and compliance activities in 2016-2018, we are confident that our compliance platform is of sounder quality, making us a safe and trusted partner".
First quarter 2019 vs. First quarter 2018 (First quarter 2019 vs. Fourth quarter 2018)
- Net interest income EUR 1,056m, -5%; -4% in local currencies (-8%, -7% in local currencies)
- Total operating income EUR 2,115m, -11%; -10% in local currencies (0%, 0% in local currencies)
- Total operating income, excl. items affecting comparability1 EUR 2,115m, -6%; -4% in local currencies (4%, 4% in local currencies)
- Total operating expenses EUR 1,452m, 6%; 7% in local currencies2 (5%, 5% in local currencies)
- Total operating expenses, excl. items affecting comparability EUR 1,357m, -1%; 0% in local currencies (9%, 10% in local currencies)
- Profit before loan losses EUR 663m, -34%; -33% in local currencies (-10%, -9% in local currencies)
- Net loan losses EUR 42m, 5%; 5% in local currencies (40%, 40% in local currencies)
- Operating profit EUR 621m, -36%; -35% in local currencies (-12%, -11% in local currencies)
- Common Equity Tier 1 capital ratio 14.6% vs.19.8% (14.6% vs. 15.5%)
- Cost/income ratio 69% vs. 58% (69% vs. 65%)
- Cost/income ratio, excl. items affecting comparability2 64% vs. 61% (64% vs. 61%)
- Loan loss ratio of 7 bps vs. 7 bps (7 bps vs. 5 bps)
- Return on equity 5.5% vs 9.0% (5.5% vs. 6.3%)
- Return on equity with perodised resolution fees 7.4% vs 10.5% (7.4% vs. 5.8%)
- Return on equity, excl. items affecting comparability1,2 6.7% vs 7.7% (6.7% vs. 7.1%)
- Diluted EPS EUR 0.10 vs. EUR 0.18 (EUR 0.10 vs. EUR 0.13)
Exchange rates used for Q1 2019 for income statement items are for DKK 7.4636, NOK 9.7459 and SEK 10.4181.
1 Excl. Items affecting comparability in Q4 2018: EUR 50m gain from revaluation of Euroclear, EUR 38m after tax, and EUR 36m gain related to sale of Nordea Ejendomme. Q1 2018: EUR 135m gain from valuation model update in Denmark, EUR 105m after tax.
2 Excl. Items affecting comparability in Q1 2019: EUR 95m non-deductible expense related to provision for AML-related matters In Q4 2018: EUR 141m loss from impairment of goodwill in Russia.
|2019||2018||Chg %||curr. %||2018||Chg %||curr. %|
|Net interest income||1,056||1,142||-8||-7||1,116||-5||-4|
|Net fee and commission income||737||720||2||3||770||-4||-3|
|Net result from items at fair value||264||182||45||41||441||-40||-40|
|Profit from associated undertakings and joint|
|ventures accounted for under the equity method||14||15||28|
|Other operating income||44||60||-27||-25||23||91||96|
|Total operating income||2,115||2,119||0||0||2,378||-11||-10|
|Depreciation, amortisation and impairment|
|charges of tangible and intangible assets||-140||-250||-44||-44||-71||97||99|
|Total operating expenses||-1,452||-1,384||5||5||-1,372||6||7|
|Profit before loan losses||663||735||-10||-9||1,006||-34||-33|
|Net loan losses||-42||-30||40||40||-40||5||5|
|Income tax expense||-178||-200||-11||-11||-229||-22||-21|
|Net profit for the period||443||505||-12||-11||737||-40||-39|
|Business volumes, key items 1|
|31 Mar||31 Dec||Local||31 Mar||Local|
|2019||2018||Chg %||curr. %||2018||Chg %||curr. %|
|Loans to the public||325.6||308.3||5.6||5.5||310.9||4.7||5.0|
|Loans to the public, excl. repos||300.6||291.6||3.1||3.0||287.5||4.6||4.9|
|Deposits and borrowings from the public||176.3||165.0||6.9||6.9||174.0||1.3||1.3|
|Deposits from the public, excl. repos||166.6||160.2||4.0||4.0||161.0||3.5||3.4|
|Assets under management||300.2||282.6||6.2||320.1||-6.2|
|Ratios and key figures 2|
|2019||2018||Chg %||2018||Chg %|
|Diluted earnings per share, EUR||0.10||0.13||-23||0.18||-44|
|EPS, rolling 12 months up to period end, EUR||0.68||0.76||-11||0.72||-6|
|Share price1, EUR||6.80||7.30||-7||8.66||-21|
|Total shareholders' return, %||3.3||-17.5||-3.9|
|Equity per share1, EUR||7.55||8.15||-7||7.63||-1|
|Potential shares outstanding1, million||4050||4,050||0||4,050||0|
|Weighted average number of diluted shares, mn||4033||4,037||0||4,038||0|
|Return on equity, %||5.5||6.3||9.0|
|Return on tangible equity, %||6.4||7.2||10.2|
|Return on Risk Exposure Amount, %||1.1||1.3||2.4|
|Return on Equity with periodised resolution fees, %||7.0||5.9||10.2|
|Cost/income ratio, %||69||65||58|
|Cost/income ratio with periodised resolution fees, %||61||67||52|
|Loan loss ratio, basis points4||7||5||40||7||0|
|Common Equity Tier 1 capital ratio1,4,5, %||14.6||15.5||19.8|
|Tier 1 capital ratio1,4,5, %||17.1||17.3||22.2|
|Total capital ratio1,4,5, %||19.5||19.9||25.2|
|Tier 1 capital1,4, EURbn||27.8||27.0||3||27.3||2|
|Risk exposure amount4, EURbn||163||156||5||123||33|
|Number of employees (FTEs)1||29,284||28,990||1||30,082||-3|
|Economic capital1, EURbn||28.2||26.6||6||26.2||8|
|1 End of period.|
|2 For more detailed information regarding ratios and key figures defined as Alternative performance measures, see www.nordea.com/en/investor-relations/.|
|3 Including Loans to the public reported in Assets held for sale in Q1 2018.|
|4 Including the result for the period.|
|5 Changes to the applicable capital requirements regime (for more details, please see chapter Other information).|
Key drivers of the outlook
Throughout Nordea, we are intensifying our efforts to increase business momentum and each business area has identified a number of initiatives to drive client value and revenue growth. Examples include investments in Private Banking in Norway and Sweden, the acquisition of Gjensidige Bank, new distribution channels within Asset Management and Wholesale Banking and actions to regain momentum on mortgages, where we are already starting to see results.
The key drivers behind the structural cost efficiency are increased usage of automation and robotics, the ongoing ramp-up in Poland and Estonia and outsourcing of Group Technology mainframe to IBM. We are also simplifying by harmonising products and services and leveraging scale by further consolidating common units, for instance global operations and services.
For 2021, we expect the cost base in constant currencies to be approximately 3% below the 2018 cost base excluding items affecting comparability in 20181 and cash costs are expected to be down by up to 10% in constant currencies over the same period.
Costs for 2019 are expected to be lower in constant currencies compared to 2018 excluding items affecting comparability in 2018 and 20192 and the total cash cost is expected to be lower in constant currencies over the same period.
1 Goodwill write-down of EUR 141m in Q4 2018
2 Adjusted for the goodwill write-down of EUR 141m in 2018, transaction costs of EUR 90m in 2019, higher resolution fee in 2019 and provision of EUR 95m in Q1 2019
Our expectation for the coming quarters is that net losses will remain low and around the average level for 2018.
Given the implementation of transitional arrangements agreed with the ECB following Nordea's transfer to the Banking Union and with the aim to maintain the same nominal management buffer, the management buffer has been adjusted from a range of 50-150 bps to 40-120 bps. This is mainly a technical adjustment and hence the management buffer remains largely unchanged in nominal EUR amounts. The current level of the management buffer is approximately EUR 2.2bn (130 bps). Nordea aims to achieve a yearly increase in the dividend per share, while maintaining a strong capital position in line with the capital policy.
The entire report can be found on the below link on our website.
Nordea Group Q1 2019 Report
For further information:
|Casper von Koskull, President and Group CEO, +358 503 821 391||Christopher Rees, Group CFO, +45 5547 2377|
|Rodney Alfvén, Head of Investor Relations, +46 72 235 05 15||Sara Helweg-Larsen, Head of Group Communications, +45 2214 0000|
The information provided in this stock exchange release was submitted for publication through the agency of the contact persons set out above at 07:30 EET (06:30 CET) on 30 April 2019.
We build strong and close relationships through our engagement with customers and society. Whenever people strive to reach their goals and realise their dreams, we are there to provide relevant financial solutions. We are the largest bank in the Nordic region and among the ten largest financial groups in Europe in terms of total market capitalisation with around 11 million customers. The Nordea share is listed on the Nasdaq Helsinki, Nasdaq Copenhagen and Nasdaq Stockholm exchanges. Read more about us on nordea.com.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact email@example.com or visit www.rns.com.
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Følg saker fra GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra GlobeNewswire
Fortuna CEO purchases company shares17.5.2019 21:00:00 CEST | Pressemelding
VANCOUVER, British Columbia, May 17, 2019 (GLOBE NEWSWIRE) -- Fortuna Silver Mines Inc. (NYSE: FSM) (TSX: FVI) reports that Jorge A. Ganoza, Chief Executive Officer of the Company, has increased his equity position in the Company by acquiring 170,000 common shares on the open market at an average price of US$2.59 per share. An insider report filing reflecting the share acquisition has been made on the SEDI website at www.sedi.ca. About Fortuna Silver Mines Inc. Fortuna is a growth oriented, precious metal producer with its primary assets being the Caylloma silver mine in southern Peru, the San Jose silver-gold mine in Mexico and the Lindero gold Project, currently under construction, in Argentina. The Company is selectively pursuing acquisition opportunities throughout the Americas and in select other areas. For more information, please visit its website at www.fortunasilver.com. ON BEHALF OF THE COMPANY Carlos Baca Investor Relations Manager Trading symbols: NYSE: FSM | TSX: FVI Inves
Oxford Immunotec Welcomes Updated CDC Recommendations for Tuberculosis Screening and Testing of Healthcare Personnel17.5.2019 15:25:00 CEST | Pressemelding
OXFORD, United Kingdom and MARLBOROUGH, Mass., May 17, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a global, high-growth diagnostics company, today announced that it welcomes the updated Tuberculosis Screening, Testing, and Treatment of U.S. Health Care Personnel: Recommendations from the National Tuberculosis Controllers Association and CDC, 2019, published by the U.S. Centers for Disease Control and Prevention (CDC)1. These guidelines increase the focus on eradicating tuberculosis (TB) disease in the United States through an individual risk-based approach to screening and treatment for Healthcare Personnel (HCP). Key highlights from the updated guidelines include: Recommendation for TB Screening and Individual Based TB Risk Assessment on Hire : continue baseline screening of all HCPs upon hire with the addition of an individual risk assessment Recommendation to Focus Serial Testing on Higher Risk Individuals: decision to perform TB testing afte
First Dolby Cinema Opens in Germany with Kinopolis Gruppe in Munich17.5.2019 14:30:00 CEST | Pressemelding
MUNICH, Germany, May 17, 2019 (GLOBE NEWSWIRE) -- Dolby Laboratories, Inc. (NYSE:DLB) and Kinopolis Gruppe today announced the opening of the first Dolby Cinema in Germany at the renowned Mathäser Palast in Munich. Film fans can now enjoy the very best cinema presentation in the heart of the city, following the opening of the highly-anticipated site. Dolby Cinema combines Dolby Vision, Dolby Atmos, and bespoke design to create the perfect environment to be fully immersed in the storytelling of a film. Dolby Vision is presented through a dual 4K laser, High Dynamic Range (HDR) projector system, and boasts a spectacular, ultra vivid picture. Compared to standard screens, the Dolby Vision image is twice as bright, 500 times the contrast ratio, has blacker blacks, and an unsurpassed colour palette. Cutting-edge Dolby Atmos sound transports viewers into the scene, filling the cinema with a soundscape that flows all around and above the audience. Dolby works with each cinema location to crea
Four Progressive Leaders to Receive the 2019 YPO Global Innovation Awards 17.5.2019 08:00:00 CEST | Pressemelding
Thirst CEO Mina Guli, RaySearch Laboratories AB CEO Johan Löf, Malwarebytes CEO Marcin Kleczynski & Apeel CEO James Rogers honored NEW YORK, May 17, 2019 (GLOBE NEWSWIRE) -- YPO, the premier global leadership organization for more than 27,000 chief executives, today announced the winners of its prestigious Global Innovation Awards. Presented in conjunction with YPO Innovation Week, the Global Innovation Awards annually recognizes YPO members who are making an impact through transformation around the globe in four categories: Social Impact, Medical, Technology, and Manufacturing. “Our goal for the 2019 Global Innovation Award winners is to recognize YPO member companies that are creating scalable solutions which address challenges both at a local and/or global level,” said Mohamed Alkady, YPO Global Innovation Awards Chair. “Each of these winners represent their category with glaring leadership and, most importantly, a clear mission and vision. This extraordinary group have demonstrated
Dr. Deep Saini appointed as Dalhousie University’s 12th President16.5.2019 21:09:00 CEST | Pressemelding
Halifax, NS, May 16, 2019 (GLOBE NEWSWIRE) -- Dalhousie University’s Board of Governors announced today that Dr. Deep Saini has been appointed as the university’s 12th President and Vice-Chancellor. Dr. Saini, who is currently Vice-Chancellor and President of the University of Canberra in Australia, was the unanimous choice of the search committee. He is an accomplished leader who combines significant Canadian post-secondary experience with a global outlook; a distinguished scientist whose belief in the transformative power of education has defined his life’s journey; and a warm, genuine and inspiring individual ready to build on Dal’s 200 years of achievement and chart a course towards even greater success in our third century ahead. “I am honoured and humbled by the opportunity to serve as the 12th President and Vice-Chancellor of Dalhousie University,” says Dr. Saini. “The university’s singular commitment to its anchor role in the region’s economic and social development is fittingl
PureCircle and Merisant Renew Stevia Supply Agreement16.5.2019 18:00:00 CEST | Pressemelding
Leading Tabletop Sweetener Company Will Increase Its Purchases of Great-Tasting Ingredients From Top Global Stevia Supplier CHICAGO, May 16, 2019 (GLOBE NEWSWIRE) -- PureCircle (LSE: PURE), the world’s leading producer and innovator of stevia sweeteners, has entered into a new stevia supply agreement with Merisant, one of the world’s leading producers of low- and zero-calorie tabletop sweeteners for consumers. This new and expanded partnership will help to ensure Merisant’s long-term supply of the best-tasting stevia ingredients. Merisant has been a partner and customer of PureCircle for the last ten years. Merisant’s sweetener products are sold in more than 90 countries worldwide. This new agreement focuses on the supply to Merisant of PureCircle’s next generation stevia sweetener ingredients like Reb M. PureCircle announced last year that it significantly increased its capacity to supply Reb M to consumer product companies. PureCircle’s Reb M is a next generation zero-calorie sweeten